Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

The American Journal of Cardiology
George Bakris

Abstract

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are recognized to reduce cardiovascular and renal morbidity and mortality, which is primarily attributed to their antihypertensive effects. Activation of the renin-angiotensin system (RAS) may also play an important role in the pathogenesis of cardiovascular and renal disease through blood pressure-independent mechanisms mediated by angiotensin II. Thus, inhibiting the RAS with either an ARB or an ACE inhibitor may confer additional benefit in people with advanced nephropathy that cannot be explained totally by reductions in blood pressure. Preclinical evidence suggests that blood pressure lowering is not solely responsible for the organ and tissue protective effects of ACE inhibitors or ARBs. Furthermore, clinical studies evaluating effects on end organs and surrogate markers have shown that these agents have blood pressure-independent effects. There is also intriguing evidence that agents in the same class may differ in their effects on renal function despite similar blood pressure control. Support for blood pressure-independent effects comes from outcome studies. Agents evaluated in such studies and that appear to have effects independent ...Continue Reading

References

Jun 7, 1995·Molecular and Cellular Biochemistry·W LinzB A Schölkens
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
May 23, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·M KitakazeM Hori
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Apr 23, 2002·Journal of Human Hypertension·M Miyazaki, S Takai
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Nov 15, 2003·Lancet·Fiona Turnbull, UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Dec 18, 2003·Clinical and Experimental Pharmacology & Physiology·Yi-Chun ZhuTai Yao
Nov 9, 2004·The New England Journal of Medicine·Eugene BraunwaldUNKNOWN PEACE Trial Investigators
Aug 12, 2006·Mayo Clinic Proceedings·Michael F O'Rourke, James B Seward
Mar 29, 2007·Diabetes Care·Hirofumi MakinoUNKNOWN INNOVATION Study Group
Apr 7, 2007·Journal of Hypertension·UNKNOWN Blood Pressure Lowering Treatment Trialists' CollaborationS MacMahon
Apr 25, 2007·Hypertension·Gary F MitchellUNKNOWN Prevention of Events With Angiotensin-Converting Enzyme Inhibition Investigators
Jun 16, 2007·Nephron. Physiology·Gunter Wolf, Fuad N Ziyadeh
Aug 10, 2007·Current Diabetes Reports·Subramaniam Pennathur, Jay W Heinecke
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
May 23, 2008·Kidney International·George BakrisUNKNOWN AMADEO Study Investigators

❮ Previous
Next ❯

Citations

Nov 19, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kaushik P PatelHong Zheng
Mar 9, 2012·Vascular Health and Risk Management·Theodore W Kurtz, Takashi Kajiya
Feb 28, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ahmet AdiyamanArif Elvan
Sep 13, 2011·Expert Opinion on Emerging Drugs·Ulrike Muscha SteckelingsMichael Bader
Sep 4, 2010·Expert Opinion on Investigational Drugs·Graziano RiccioniNicolantonio d'Orazio
Feb 10, 2016·BMC Complementary and Alternative Medicine·Chien-Tsong LinCheng-Nan Chen
Jun 17, 2015·Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne·Dana PopD Zdrenghea
Apr 20, 2012·International Journal of Cardiology·Hae Chang JeongUNKNOWN Other Korea Acute Myocardial Infarction Registry Investigators
Aug 19, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·John C NewmanNir Barzilai
Jun 18, 2011·American Journal of Hypertension·Conrad Sernia, Lindsay Brown
Jan 9, 2013·Hypertension·Pontus B Persson
Feb 3, 2011·Cardiology in Review·Howard S WeintraubArthur Schwartzbard
Aug 5, 2010·Acta Biotheoretica·François Guillaud, Patrick Hannaert
Feb 3, 2011·Annals of Medicine·Tommaso Gori, Thomas Münzel
Jul 21, 2020·Clinical and Experimental Pharmacology & Physiology·José Wilson do Nascimento CorrêaLusiane Maria Bendhack
Apr 2, 2011·American Journal of Physiology. Renal Physiology·Fabio SangalliAndrea Remuzzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.